ORBIS project – where have we arrived?
The Open Research Biopharmaceutical Internships Support project (ORBIS) was a response to the scientific, economic, and social challenge of increasing the effectiveness and productivity of the drug development process, both for innovative and (super)generic drugs. The overarching objective of the O...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Poznan University of Medical Sciences
2023-09-01
|
| Series: | Journal of Medical Science |
| Subjects: | |
| Online Access: | https://jms.ump.edu.pl/index.php/JMS/article/view/936 |
| _version_ | 1797666977885454336 |
|---|---|
| author | Marcin Skotnicki Emilia Jakubowska Wojciech Smułek Sharon Davin Lidia Tajber Janina Lulek |
| author_facet | Marcin Skotnicki Emilia Jakubowska Wojciech Smułek Sharon Davin Lidia Tajber Janina Lulek |
| author_sort | Marcin Skotnicki |
| collection | DOAJ |
| description |
The Open Research Biopharmaceutical Internships Support project (ORBIS) was a response to the scientific, economic, and social challenge of increasing the effectiveness and productivity of the drug development process, both for innovative and (super)generic drugs. The overarching objective of the ORBIS project was to form a transnational and intersectoral cooperation network of academic and industrial organisations delivering a joint research programme. The research aimed at improving the preclinical pathway of drug development and manufacturing, focusing on technological and methodological improvements of the existing processes. The participating staff from all institutions have developed new skills, were exposed to new work and research environments, and have significantly broadened their career perspectives. More than 450 months of secondments were completed, and over 175 early-stage and experienced researchers participated in the exchange. This review aims to present some aspects of the scientific, training, and organisational activities of the consortium, bringing together representatives of both the academic sector as well as small and medium-sized pharmaceutical enterprises.
|
| first_indexed | 2024-03-11T20:06:27Z |
| format | Article |
| id | doaj.art-680eec7f93ed4baabaa11b551f95802c |
| institution | Directory Open Access Journal |
| issn | 2353-9798 2353-9801 |
| language | English |
| last_indexed | 2024-03-11T20:06:27Z |
| publishDate | 2023-09-01 |
| publisher | Poznan University of Medical Sciences |
| record_format | Article |
| series | Journal of Medical Science |
| spelling | doaj.art-680eec7f93ed4baabaa11b551f95802c2023-10-03T16:12:50ZengPoznan University of Medical SciencesJournal of Medical Science2353-97982353-98012023-09-0192310.20883/medical.e936ORBIS project – where have we arrived?Marcin Skotnicki0Emilia Jakubowska1Wojciech Smułek2Sharon Davin3Lidia Tajber4Janina Lulek5Chair and Department of Pharmaceutical Technology, Faculty of Pharmacy, Poznan University of Medical Sciences, PolandChair and Department of Pharmaceutical Technology, Faculty of Pharmacy, Poznan University of Medical Sciences, PolandInstitute of Technology and Chemical Engineering, Poznan University of Technology, PolandApplied Process Company Ltd., Dublin, IrelandSchool of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, College Green, Dublin 2, IrelandChair and Department of Pharmaceutical Technology, Faculty of Pharmacy, Poznan University of Medical Sciences, Poland The Open Research Biopharmaceutical Internships Support project (ORBIS) was a response to the scientific, economic, and social challenge of increasing the effectiveness and productivity of the drug development process, both for innovative and (super)generic drugs. The overarching objective of the ORBIS project was to form a transnational and intersectoral cooperation network of academic and industrial organisations delivering a joint research programme. The research aimed at improving the preclinical pathway of drug development and manufacturing, focusing on technological and methodological improvements of the existing processes. The participating staff from all institutions have developed new skills, were exposed to new work and research environments, and have significantly broadened their career perspectives. More than 450 months of secondments were completed, and over 175 early-stage and experienced researchers participated in the exchange. This review aims to present some aspects of the scientific, training, and organisational activities of the consortium, bringing together representatives of both the academic sector as well as small and medium-sized pharmaceutical enterprises. https://jms.ump.edu.pl/index.php/JMS/article/view/936international and intersectoral projectdrug synthesissolid state pharmaceuticalsoral and skin deliverybiorelevant dissolutionbiomedical analysis |
| spellingShingle | Marcin Skotnicki Emilia Jakubowska Wojciech Smułek Sharon Davin Lidia Tajber Janina Lulek ORBIS project – where have we arrived? Journal of Medical Science international and intersectoral project drug synthesis solid state pharmaceuticals oral and skin delivery biorelevant dissolution biomedical analysis |
| title | ORBIS project – where have we arrived? |
| title_full | ORBIS project – where have we arrived? |
| title_fullStr | ORBIS project – where have we arrived? |
| title_full_unstemmed | ORBIS project – where have we arrived? |
| title_short | ORBIS project – where have we arrived? |
| title_sort | orbis project where have we arrived |
| topic | international and intersectoral project drug synthesis solid state pharmaceuticals oral and skin delivery biorelevant dissolution biomedical analysis |
| url | https://jms.ump.edu.pl/index.php/JMS/article/view/936 |
| work_keys_str_mv | AT marcinskotnicki orbisprojectwherehavewearrived AT emiliajakubowska orbisprojectwherehavewearrived AT wojciechsmułek orbisprojectwherehavewearrived AT sharondavin orbisprojectwherehavewearrived AT lidiatajber orbisprojectwherehavewearrived AT janinalulek orbisprojectwherehavewearrived |